<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Morse | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/tieagenda4/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/tieagenda4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Morse.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">67fdb79228b0a567629b7b6c254447b1</guid>
				<title>Morse posted an update: LncRNA RP11-84E24.3 was up-regulated in both glioma tissues [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42677/</link>
				<pubDate>Sun, 09 Feb 2025 10:40:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>LncRNA RP11-84E24.3 was up-regulated in both glioma tissues and cell lines. LncRNA RP11-84E24.3 overexpression enhanced the proliferation, migration and invasion of glioma cells while reducing apoptosis. This was associated with a decrease in E-cadherin expression and an increase in N-cadherin and Vimentin expression. <a href="https://www.selleckchem.com/products/deutenzalutamide.html" rel="nofollow ugc">Hormones antagonist</a> LncRNA&hellip;<span class="activity-read-more" id="activity-read-more-42677"><a href="http://www.nationalboardinstitute.com/activity/p/42677/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a498a221a9aff241f763eaa20955b73b</guid>
				<title>Morse posted an update: os to verify the capability of laboratory scanners in the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38213/</link>
				<pubDate>Tue, 04 Feb 2025 10:13:06 -0800</pubDate>

									<content:encoded><![CDATA[<p>os to verify the capability of laboratory scanners in the implant workflow.</p>
<p> To review leadership for dentists in patient facing, primary care dental practice.</p>
<p> A three stage systematic review with narrative synthesis included stage 1 a scoping overview of management and leadership policy context; stage 2 systematic review of review of&hellip;<span class="activity-read-more" id="activity-read-more-38213"><a href="http://www.nationalboardinstitute.com/activity/p/38213/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a8aa5e9b99740df7df7a3ec689dc6905</guid>
				<title>Morse posted an update: Sickle Cell Disease (SCD) is a chronic hemolytic disorder [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36509/</link>
				<pubDate>Sun, 02 Feb 2025 10:50:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>Sickle Cell Disease (SCD) is a chronic hemolytic disorder associated with frequent pain episodes, end organ damage and a shortened lifespan. Currently there exist no disease specific targeted therapies for the treatment of acute vaso-occlusive crisis (VOC) and management with analgesics and hydration is purely supportive. Improvement in&hellip;<span class="activity-read-more" id="activity-read-more-36509"><a href="http://www.nationalboardinstitute.com/activity/p/36509/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5cae6028ffcb7a3cbad7bc41376f6496</guid>
				<title>Morse posted an update: Of those who did not find it easy, 80% reported that two to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34729/</link>
				<pubDate>Fri, 31 Jan 2025 10:55:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>Of those who did not find it easy, 80% reported that two to three insertions were required to achieve comfort. A maximum of five insertions was mentioned to achieve comfort. The majority who had used the cup (&gt;90%) reported they would continue to use it at each follow-up visit.</p>
<p> The menstrual cup was well accepted among this student&hellip;<span class="activity-read-more" id="activity-read-more-34729"><a href="http://www.nationalboardinstitute.com/activity/p/34729/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">10b77ddaa8fc013871ffa62542cf4bd4</guid>
				<title>Morse posted an update: 32 for lower subgroup, 0.73 for higher subgroup). The [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33875/</link>
				<pubDate>Thu, 30 Jan 2025 10:57:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>32 for lower subgroup, 0.73 for higher subgroup). The concordance rates with qMSP were 94.4% (PSQ) and 90.2% (MGMT-STP27). Discordant results were restricted to tumors with qMSP ratios ≤4 and PSQ mean methylation rate ≤25%. Despite a shorter survival in MGMT-promoter-methylated patients with lower methylation according to qMSP, these patients had&hellip;<span class="activity-read-more" id="activity-read-more-33875"><a href="http://www.nationalboardinstitute.com/activity/p/33875/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a4c8e89af899f03c307e994ccaf64bae</guid>
				<title>Morse posted an update: In osteoarthritis (OA), the synthesis and decomposition of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32001/</link>
				<pubDate>Tue, 28 Jan 2025 17:45:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>In osteoarthritis (OA), the synthesis and decomposition of the extracellular matrix (ECM) are imbalanced. High expression levels of Wnt1-inducible signaling pathway protein 1 (WISP1) promote the synthesis of matrix metalloproteinases and induce the degradation of cartilage, which aggravates the OA. The aim of this study was to explore the role of&hellip;<span class="activity-read-more" id="activity-read-more-32001"><a href="http://www.nationalboardinstitute.com/activity/p/32001/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a0e7a35e871c7d6b5f666134f05b3fcc</guid>
				<title>Morse became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31950/</link>
				<pubDate>Tue, 28 Jan 2025 17:41:40 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>